ZA9610714B - Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet - Google Patents
Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tabletInfo
- Publication number
- ZA9610714B ZA9610714B ZA9610714A ZA9610714A ZA9610714B ZA 9610714 B ZA9610714 B ZA 9610714B ZA 9610714 A ZA9610714 A ZA 9610714A ZA 9610714 A ZA9610714 A ZA 9610714A ZA 9610714 B ZA9610714 B ZA 9610714B
- Authority
- ZA
- South Africa
- Prior art keywords
- tablet
- preparing
- pharmaceutically acceptable
- acceptable salt
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK144895 | 1995-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9610714B true ZA9610714B (en) | 1997-06-30 |
Family
ID=8104933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9610714A ZA9610714B (en) | 1995-12-20 | 1996-12-19 | Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6036975A (xx) |
| EP (1) | EP0869783B1 (xx) |
| JP (1) | JP2000515489A (xx) |
| CN (1) | CN1147295C (xx) |
| AR (1) | AR004395A1 (xx) |
| AT (1) | ATE234085T1 (xx) |
| AU (1) | AU1190097A (xx) |
| BR (1) | BR9612057A (xx) |
| CA (1) | CA2244396A1 (xx) |
| CZ (1) | CZ293422B6 (xx) |
| DE (1) | DE69626676T2 (xx) |
| DK (1) | DK0869783T3 (xx) |
| EE (1) | EE9800186A (xx) |
| ES (1) | ES2191781T3 (xx) |
| HR (1) | HRP960598A2 (xx) |
| HU (1) | HU224030B1 (xx) |
| IL (1) | IL124356A (xx) |
| MX (1) | MX9803918A (xx) |
| NO (1) | NO316869B1 (xx) |
| NZ (1) | NZ324674A (xx) |
| PL (1) | PL186915B1 (xx) |
| RO (1) | RO117589B1 (xx) |
| RU (1) | RU2166939C2 (xx) |
| TR (1) | TR199801126T2 (xx) |
| TW (1) | TW430561B (xx) |
| WO (1) | WO1997022340A1 (xx) |
| ZA (1) | ZA9610714B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9802973D0 (sv) | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
| US6599530B2 (en) * | 1998-09-14 | 2003-07-29 | Orion Corporation | Oral compacted composition comprising catechol derivatives |
| US6660303B2 (en) * | 1999-12-06 | 2003-12-09 | Edward Mendell & Co. | Pharmaceutical superdisintegrant |
| CA2311734C (en) * | 2000-04-12 | 2011-03-08 | Bristol-Myers Squibb Company | Flash-melt oral dosage formulation |
| WO2005028621A2 (en) * | 2003-09-15 | 2005-03-31 | Vitra Bioscience, Inc. | Assays with primary cells |
| WO2007112098A2 (en) * | 2006-03-24 | 2007-10-04 | The Texas A & M University System And Safe Et Al | Uses of diphenyl/diphenylamine carboxylic acids |
| TWI405574B (zh) * | 2007-06-21 | 2013-08-21 | Otsuka Pharma Co Ltd | 藥學固體製劑及其製造方法 |
| US8367427B2 (en) * | 2008-08-20 | 2013-02-05 | Baxter International Inc. | Methods of processing compositions containing microparticles |
| CA3036053A1 (en) * | 2016-09-07 | 2018-03-15 | Celgene Corporation | Tablet compositions |
| CN111184707B (zh) * | 2020-02-20 | 2021-04-27 | 中山大学 | 托芬那酸或其药学上可接受的盐在制备预防和/或治疗新型冠状病毒炎症药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE116061C (xx) * | ||||
| FI89004C (fi) * | 1988-02-16 | 1993-08-10 | Pertti J Neuvonen | Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat |
| IT1276689B1 (it) * | 1995-06-09 | 1997-11-03 | Applied Pharma Res | Forma farmaceutica solida ad uso orale |
-
1996
- 1996-12-10 TW TW085115247A patent/TW430561B/zh active
- 1996-12-18 AR ARP960105763A patent/AR004395A1/es active IP Right Grant
- 1996-12-19 BR BR9612057A patent/BR9612057A/pt not_active Application Discontinuation
- 1996-12-19 US US09/091,526 patent/US6036975A/en not_active Expired - Fee Related
- 1996-12-19 CN CNB961998652A patent/CN1147295C/zh not_active Expired - Fee Related
- 1996-12-19 AU AU11900/97A patent/AU1190097A/en not_active Abandoned
- 1996-12-19 AT AT96943021T patent/ATE234085T1/de not_active IP Right Cessation
- 1996-12-19 NZ NZ324674A patent/NZ324674A/xx unknown
- 1996-12-19 TR TR1998/01126T patent/TR199801126T2/xx unknown
- 1996-12-19 CA CA002244396A patent/CA2244396A1/en not_active Abandoned
- 1996-12-19 IL IL12435696A patent/IL124356A/en active IP Right Grant
- 1996-12-19 DE DE69626676T patent/DE69626676T2/de not_active Expired - Fee Related
- 1996-12-19 ES ES96943021T patent/ES2191781T3/es not_active Expired - Lifetime
- 1996-12-19 WO PCT/DK1996/000548 patent/WO1997022340A1/en active IP Right Grant
- 1996-12-19 HR HR1448/95A patent/HRP960598A2/hr not_active Application Discontinuation
- 1996-12-19 PL PL96327584A patent/PL186915B1/pl not_active IP Right Cessation
- 1996-12-19 ZA ZA9610714A patent/ZA9610714B/xx unknown
- 1996-12-19 CZ CZ19981943A patent/CZ293422B6/cs not_active IP Right Cessation
- 1996-12-19 RO RO98-01088A patent/RO117589B1/ro unknown
- 1996-12-19 EP EP96943021A patent/EP0869783B1/en not_active Expired - Lifetime
- 1996-12-19 RU RU98113714/14A patent/RU2166939C2/ru active
- 1996-12-19 DK DK96943021T patent/DK0869783T3/da active
- 1996-12-19 HU HU9903410A patent/HU224030B1/hu not_active IP Right Cessation
- 1996-12-19 EE EE9800186A patent/EE9800186A/xx unknown
- 1996-12-19 JP JP09522437A patent/JP2000515489A/ja active Pending
-
1998
- 1998-05-18 MX MX9803918A patent/MX9803918A/es unknown
- 1998-06-19 NO NO19982875A patent/NO316869B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5538098A (en) | A slow releasing physiologically active pharmaceutical and method of preparation thereof | |
| ZA944773B (en) | Sustained release compositions and a method of preparing pharmaceutical compositions and a method of preparing pharmaceutical compositions | |
| HUT53068A (en) | Process for producing benzoic acid and phenylacetic acid derivatives and pharmaceutical compositions comprising such active ingredient | |
| HUT64065A (en) | Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HUT60466A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
| EP0504938A3 (en) | Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient | |
| HUP0004383A3 (en) | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient | |
| HUT51254A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HUT52089A (en) | Process for producing triazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT59314A (en) | Process for producing pharmaceutical composition comprising minocylcine active ingredient and suitable for a single daily administration | |
| HUT58060A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
| HUT49625A (en) | Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient | |
| CZ121199A3 (cs) | Farmaceuticky účinné mikrokuličky kyseliny valprové k peronálnímu podávání | |
| ZA988718B (en) | Drug formulation having controlled release of active compound | |
| ZA9610714B (en) | Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet | |
| GB2226804B (en) | Process for preparing microcapsules providing the rapid release of a drug as active ingredient | |
| GB9324045D0 (en) | Sustained release compositions and a method of preparing pharmaceutical compositions | |
| IL124841A (en) | Pharmaceutical compositions comprising liposomal prostaglandin a method of preparing such compositions and the use of liposomal prostaglandin for said preparation | |
| PL316113A1 (en) | Granulated product or tablet containing an effervescent system and a pharmaceutically active substance as well as method of obtaining them | |
| HUT59319A (en) | Pharmaceutical compositions with controlled release of active ingredient and process for producing same | |
| HUT75029A (en) | Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient | |
| HUT48607A (en) | Herbicides comprising substituted triazolinone derivatives as active ingredient and process for producing substituted triazolinone derivatives | |
| IL118202A0 (en) | Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours | |
| HUT51105A (en) | Pesticide comprising substituted acrylic acid ester derivatives as active ingredient and process for producing the active ingredients | |
| HUT48192A (en) | Process for producing catechol carboxylic acid derivatives and pharmaceuticals comprising such active ingredient |